This seems reasonable to me at a high level (not including relative costs of tests vs. vaccines, assuming we can reliably enough test, and that and likelihood of having waning antibodies would vary enough individually that this would make sense).
I’m not sure how one would know what to attribute breakthrough cases to with being in some kind of laboratory environment where viral dose was measured and antibodies were measured and we saw who did and didn’t get sick… I’m not a medical professional so maybe there’s things I’m missing here.
Yeah, I’m not really imagining a lab test on the matter. It seems like the sort of thing where someone with the right dataset could do some clever math and back out a reasonable estimate.
This seems reasonable to me at a high level (not including relative costs of tests vs. vaccines, assuming we can reliably enough test, and that and likelihood of having waning antibodies would vary enough individually that this would make sense).
I’m not sure how one would know what to attribute breakthrough cases to with being in some kind of laboratory environment where viral dose was measured and antibodies were measured and we saw who did and didn’t get sick… I’m not a medical professional so maybe there’s things I’m missing here.
Yeah, I’m not really imagining a lab test on the matter. It seems like the sort of thing where someone with the right dataset could do some clever math and back out a reasonable estimate.